NEW YORK (GenomeWeb News) - Fluidigm said last week that the Department of Chemical Pathology at the Chinese University of Hong Kong has licensed its BioMark real-time PCR system.
Fluidigm said that the lab is using the system to study viruses associated with cancer, to detect somatic mutations in genes, and to develop gene expression profiles, among other molecular diagnostic research projects.
Financial terms of the agreement were not provided.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.